Market Insights Consumer OTC Pharmaceuticals

Wound Care - Portugal

Portugal

Revenue in the Wound Care market amounts to €16.16 in 2024. The market is expected to grow annually by 0.43% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€975 in 2024).
In relation to total population figures, per person revenues of €1.58 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Wound Care market in Portugal is experiencing steady growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Portugal are driving the demand for advanced wound care products.

Patients are increasingly seeking products that promote faster healing and minimize pain and discomfort. This has led to a growing demand for innovative wound dressings, such as hydrocolloids and foam dressings, which provide optimal moisture balance and enhance the healing process. Additionally, there is a preference for products that are easy to use and require minimal maintenance, as patients value convenience and simplicity in their wound care routines.

Trends in the market further contribute to the growth of the Wound Care market in Portugal. One significant trend is the increasing focus on chronic wound management. With the aging population and rising prevalence of chronic diseases such as diabetes, there is a growing need for specialized wound care products that address the unique challenges of chronic wounds.

This includes products that facilitate wound debridement, promote tissue regeneration, and prevent infection. The market is also witnessing a shift towards the use of advanced technologies, such as negative pressure wound therapy and bioactive dressings, which offer enhanced healing outcomes. Local special circumstances in Portugal also play a role in the development of the Wound Care market.

The country has a well-established healthcare system that provides universal access to healthcare services. This ensures that patients have access to the necessary wound care treatments and products. Additionally, Portugal has a high prevalence of chronic diseases, particularly diabetes, which increases the demand for wound care products.

The country's aging population also contributes to the growth of the market, as older individuals are more susceptible to chronic wounds and require specialized care. Underlying macroeconomic factors further support the growth of the Wound Care market in Portugal. The country has experienced overall economic stability and steady growth in recent years, which has positively impacted the healthcare sector.

Increased government expenditure on healthcare and ongoing investments in medical research and development have created a favorable environment for the development and adoption of innovative wound care products. Furthermore, the presence of a well-regulated healthcare market ensures that products meet stringent quality standards, instilling confidence in both healthcare professionals and patients. In conclusion, the Wound Care market in Portugal is experiencing steady growth driven by customer preferences for advanced wound care products, trends in the market towards chronic wound management and advanced technologies, local special circumstances such as a well-established healthcare system and a high prevalence of chronic diseases, and underlying macroeconomic factors including economic stability and government investments in healthcare.

These factors collectively contribute to the development and expansion of the Wound Care market in Portugal.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.